ZeroHarm Sciences Private Limited - Zeroharm Narie Fertility Formula Tablet

Recommendation: Upheld | Medium: Suo Motu - NAMS (TAMS)

In the absence of required action on or before the prescribed due date, CCC considered this complaint exparte Claim - “What to Expect in 90 Days: Month 1: “Releasing healthy eggs”, Month 2: “Timely ovulation”, Month 3: “Happily conceive”, were not substantiated with clinical evidence or with clinical third party test reports for product efficacy to prove that the advertiser’s product releases healthy eggs in Month 1, ensures timely ovulation in Month 2, and results in conception within 90 days, as claimed. The source and date for the claims is not indicated in the advertisement. The claims are misleading by exaggeration and are likely to lead to widespread disappointment in the minds of consumers. This advertisement is in contravention of Chapter I, Clauses 1.1, 1.2, 1.4 and 1.5 of the ASCI Code and ASCI Guidelines on Advertising of Foods & Beverages (F&B). The complaint was Upheld